Hazard ratios for the composite primary end-point from sub-group analyses of patents presenting with and without an acute coronary syndrome. Hazard ratios.

Slides:

Advertisements

Similar presentations

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Advertisements

The results of systematic literature search of published studies investigating the potential uses of WhatsApp within healthcare. The results of systematic.

Scanning Electron Microscope (SEM) images of the dialysis membranes: cross-section (a) 6 kDa, no polyvinylpyrrolidone (PVP); (b) 12 kDa, 2% PVP; (c) 16 kDa,

Chart 3: Working example of oxygen section for hospital prescription charts (two panels are required on the prescription chart because oxygen may change.

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

Masashi Maeda et al. Heart Asia 2013;5:7-14

Preprocedure patient ranking of aspects of their care important for obtaining satisfaction with their colonoscopy experience (1=high, 15=low for importance)

Subgroup analysis of the 17 trials comparing haloperidol and placebo in schizophrenia (outcome: response rate). Subgroup analysis of the 17 trials comparing.

The Arclight illumination uses a light emitting diode placed directly below the viewing hole, facing the patient, creating a near-axial light source unlike.

Relationship between the premature ventricular contraction (PVC) prevalence and change in left ventricular diastolic dimension (ΔLVDd) during the 4-year.

Comparative foreign patent filing trends in India for the period 2005–2009 vs 2010–2014. Comparative foreign patent filing trends in India for the period.

Time course of changes in left ventricular ejection fraction (LVEF) and left ventricular diastolic dimension (LVDd) in 13 patients with the development.

Relationship between the change in left ventricular ejection fraction (ΔLVEF) and change in left ventricular diastolic dimension (ΔLVDd) at 4 years at.

Algorithm for the investigation of patients with elevated cardiac troponin concentrations in the context of an alternative acute illness. Algorithm for.

Area under the receiver operating curve showing 0

Percentage of endometrial ablation procedures using balloon or microwave ablation procedures—National Institute for Health and Care Excellence guidance.

Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome (CABG-ACS) trial. Flow diagram of Coronary Artery Bypass Graft-Acute Coronary Syndrome.

The Glasgow trolley used in the study by Aladangady et al18 that inspired the first designs of the Bedside Assessment, Stabilisation and Initial Cardiorespiratory.

Mean change from baseline in 6MWD in (A) Chinese patients with PAH in PATENT-1 and (B) Chinese patients with CTEPH in CHEST-1. Mean change from baseline.

Area under the receiver operating curve showing 0

Area under the receiver operating curve showing 0

The first Bedside Assessment, Stabilisation and Initial Cardiorespiratory Support (BASICS) prototype (by PW in April 2011, reprinted with his permission).

Summary of literature search results

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Expected value of perfect implementation: population net health benefit and maximum justifiable investment if all patients who were eligible received beta.

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Diagram showing the normal progression of severe PPH

Results of comparisons of treatments in the network.

Decision tree (using the CHAID algorithm) for predicting participation in a cardiac prevention and rehabilitation programme (CPRP) among 420 Jewish and.

Area under the receiver operating curve showing 0

Percentage of percutaneous coronary interventions using drug-eluting stents in a National Health Service setting in England—National Institute for Health.

Result of coronary angiogram among patients with and without diabetes admitted with first-time acute coronary syndrome (a significant stenosis was defined.

Effect of sacubitril/valsartan on the rate of heart failure (HF) hospitalisations as a time to first event analysis and as a recurrent event analysis of.

Prasugrel versus clopidogrel; risk ratio with 95% CIs for the primary composite end point of cardiovascular death, non-fatal myocardial infarction and.

Percentage of all inpatient episodes for selected cardiovascular conditions, by sex and country of the UK, 2012/2013. Percentage of all inpatient episodes.

Percentage of individuals aged 16 and over taking cardiovascular-related prescriptions, by sex, England 2012–2013. Percentage of individuals aged 16 and.

Use of evidence-based cardiac medications before, during and after hospitalisation for the index event in (A) overall ACS population and (B) patients with.

Countries and areas of the Western Pacific region included within the scope of this study. Taiwan does not have WHO Member State status but is within this.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to minimum observed white blood cell.

Two types of VT (panel A and B) in the same patient (panel C during sinus rhythm). Two types of VT (panel A and B) in the same patient (panel C during.

Kaplan-Meier survival curves by frequency of exacerbations in patients with COPD: group A, patients with no acute exacerbations of COPD; group B, patients.

Left atrial appendage flow during atrial fibrillation, as determined by pulsed Doppler during transoesophageal echocardiography. Left atrial appendage.

Sestamibi scan of patient 5 showing a fixed defect (indicating infarction) in the anterior wall (small arrowheads) and reversible ischaemia in the septum.

The QT interval responses to different pacing rates in a patient in group I. The pacing rate was decreased from 110 to 50 beats/min and the QT interval.

Hazard ratios for the composite primary end-point from sub-group analyses of patents presenting with and without an acute coronary syndrome. Hazard ratios.

Performance of the Manchester Acute Coronary Syndromes decision rule with high-sensitivity cardiac troponin T (hs-cTnT) as the reference standard for the.

Temporal trends of AF hospitalisation per 100 patients with AF according to main hospitalisation causes between 2006 and *P value for increase trends

Cardiac MRI during the acute phase of the illness.

Standardised right ventricular perfusion images used for segmental analysis in patients with congenitally corrected TGA. (A) Transaxial (cross sectional)

Forest plot of major bleeding: the measure of the effect of morphine versus nonmorphine on major bleeding in each study was plotted using OR and 95% CI.

Performance of the Manchester Acute Coronary Syndromes decision rule in the validation study. Performance of the Manchester Acute Coronary Syndromes decision.

Angiograms of a (non-study) patient with congenitally corrected TGA

This section, cut in the frontal plane, in a human embryo at Carnegie stage 16, shows the entry of the pulmonary vein to the inferior aspect of the left.

FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.

Coloured dotplot of mortality rate per population in Scotland by age for those aged 30 to 89 years, from 1974 to 2015, stratified by sex for IHD.

Odds ratio (95% confidence intervals) of reporting respiratory symptoms in patients with treated hypothyroidism or inflammatory bowel disease (IBD) compared.

Changes in responder classification and corresponding subgroup mean FEV1 at each visit after both bronchodilators using (A) American Thoracic Society and.

Biological incorporation of the mesh.

Patent applications filed in India in the various medical device sub-sectors in India. Patent applications filed in India in the various medical device.

Determinants of moderate Cardiovascular Health Index Score (achieving three or more risk factor targets), stratified by region conventions as in figure.

Effect of sacubitril/valsartan on the rate of primary end point and component and all-cause mortality in patients randomised in the PARADIGM-HF trial according.

Proportions of the social isolation—AMI and stroke excess risk mediated by biological, behavioural, socioeconomic and health-related factors. Proportions.

Comparison of heart failure admissions rates per annum (recorded hospital admissions/ population at risk) in western developed countries 1978 to.

Subgroup analysis of associations between daily tea consumption and risk of ischaemic heart disease (IHD) according to potential baseline risk factors.

18F-NaF positron emission tomography–computed tomography (PET-CT) in abdominal aortic aneurysm disease. 18F-NaF positron emission tomography–computed tomography.

Kaplan-Meier survival curves by severity of exacerbations in patients with COPD: (1) no acute exacerbations of COPD; (2) patients with acute exacerbations.

(A) Percentage of patients achieving remission or response at week 12 or 24 after initiating ova therapy. (A) Percentage of patients achieving remission.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Performance of the Manchester Acute Coronary Syndromes decision rule in the derivation study. Performance of the Manchester Acute Coronary Syndromes decision.

Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.

Presentation transcript:

Hazard ratios for the composite primary end-point from sub-group analyses of patents presenting with and without an acute coronary syndrome. Hazard ratios for the composite primary end-point from sub-group analyses of patents presenting with and without an acute coronary syndrome. EXCELLENT trial (n=1443), 6 vs 12 months, patients presenting with ACS = 52% of the study population; PRODIGY trial (n=2013), 6 vs 24 months, patients presenting with ACS subgroup = 74% of study population; ISAR-SAFE trial (n=4000), 6 vs 12 months, patients presenting with ACS = 40% of the study population; OPTIMIZE trial (n=3119), 3 vs 12 months, patients presenting with ACS = 37% of the study population; ARTIC INTERRUPTION (n=1259), 12 vs 30 months, patients presenting with ACS = 26% of the study population; DES-LATE (n=5045), 12 vs 24 months, patients presenting with ACS = 61% of the study population and DAPT (n=9961), 12 vs 30 months, patients presenting with ACS = 43% of the study population. Simon John Wilson et al. Heart doi:10.1136/heartjnl-2016-309871 Copyright © BMJ Publishing Group Ltd & British Cardiovascular Society. All rights reserved.